
When her newborn daughter, Aniya, was diagnosed with spinal muscular atrophy, Abilene resident Hailey Weihs learned time was of the essence.
Aniya’s diagnosis affects 1 in 6,000 children, according to Johns Hopkins Medicine. Children born with SMA have missing or non-working genes responsible for producing a protein responsible for muscle control. Without enough protein, nerve cells die, causing weak and atrophied muscles.
Aniya’s neurologist prescribed her Zolgensma, a one-time gene therapy that helps the body’s nerve cells produce protein. However, Weihs said her insurance denied the doctor’s preauthorization request because Aniya’s condition was considered mild.
コメント